IL10 and pancreatic adenocarcinoma: IL10 (Figure 3I) correlates with increased risk in KIRP and pancreatic adenocarcinoma (PAAD), yet displays protective tendencies in LUSC, emphasizing its variable role across different tumor microenvironments.